Enzolytics Inc (ENZC)

[foxi]

Moderna never had a successful vaccine before covid emergency use thrust them into the mainstream. That didn't take long at all. ENZC's research has applications for covid treatment (especially in dealing with mutations and variants) and ENZC is cleverly pursuing foreign emergency use and veterinary medicine to prove viability and put pressure on the USA regulatory powers. If ENZC doesn't manufacture its own vaccines, at a minimum I'd still expect to see its target sites research become the norm for BP vaccines.

Consider medical relevance from HIV to flu to rabies in humans, feline lukemia and equine anemia in domestic animals, plus collabs with players like Intel, and it starts to look pretty solid (at least long term!). Afaik, ENZC is pushing bleeding edge technologies and like other disruptors, it's hard to gauge how quickly this will move due to lack of history/competition to compare it to.

Application of computer analysis (Artificial Intelligence - A.I.) to curate (analyze) the amino acid sequences of targeted viruses to identify the conserved, immutable, and neutralizable target sites (epitopes) on targeted viruses. Enzolytics has accomplished this goal for HIV, the Coronavirus, HTLV-1 and is in the process of doing the same for H10N3, Influenza A and B, H1N1 influenza, Respiratory syncytial virus (RSV), Ebola, Small-Pox, Tetanus, Diphtheria, Rabies, Herpes zoster, Varicella zoster, Anthrax, Elephant endotheliotropic herpesviruses, Feline Leukemia Virus, Equine Infectious Anemia Virus, and Koala retrovirus.

https://finance.yahoo.com/news/enzolytics-announces-comprehensive-therapeutic-protocol-150500114.html